1. Home
  2. RGEN vs CAE Comparison

RGEN vs CAE Comparison

Compare RGEN & CAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • CAE
  • Stock Information
  • Founded
  • RGEN 1981
  • CAE 1947
  • Country
  • RGEN United States
  • CAE Canada
  • Employees
  • RGEN N/A
  • CAE N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • CAE
  • Sector
  • RGEN Health Care
  • CAE
  • Exchange
  • RGEN Nasdaq
  • CAE Nasdaq
  • Market Cap
  • RGEN 8.0B
  • CAE 8.1B
  • IPO Year
  • RGEN N/A
  • CAE N/A
  • Fundamental
  • Price
  • RGEN $128.04
  • CAE $24.58
  • Analyst Decision
  • RGEN Buy
  • CAE Buy
  • Analyst Count
  • RGEN 12
  • CAE 3
  • Target Price
  • RGEN $172.67
  • CAE $32.00
  • AVG Volume (30 Days)
  • RGEN 830.2K
  • CAE 442.1K
  • Earning Date
  • RGEN 04-29-2025
  • CAE 05-13-2025
  • Dividend Yield
  • RGEN N/A
  • CAE N/A
  • EPS Growth
  • RGEN N/A
  • CAE N/A
  • EPS
  • RGEN N/A
  • CAE 0.88
  • Revenue
  • RGEN $650,429,000.00
  • CAE $3,275,402,649.00
  • Revenue This Year
  • RGEN $13.93
  • CAE $11.49
  • Revenue Next Year
  • RGEN $14.35
  • CAE $6.91
  • P/E Ratio
  • RGEN N/A
  • CAE $27.81
  • Revenue Growth
  • RGEN 4.88
  • CAE 9.93
  • 52 Week Low
  • RGEN $102.97
  • CAE $15.95
  • 52 Week High
  • RGEN $182.52
  • CAE $27.62
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 44.98
  • CAE 47.96
  • Support Level
  • RGEN $123.10
  • CAE $25.38
  • Resistance Level
  • RGEN $135.47
  • CAE $26.63
  • Average True Range (ATR)
  • RGEN 6.85
  • CAE 0.57
  • MACD
  • RGEN -0.74
  • CAE 0.04
  • Stochastic Oscillator
  • RGEN 19.54
  • CAE 22.05

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a global training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

Share on Social Networks: